Management of malignant ventricular arrhythmias and cardiac arrest

Critical Care Medicine

Volumn 28, Issue 10 SUPPL., 2000, Pages

  Fogel, R I ^a   Prystowsky, E N ^a  

^a Care Group   (United States)

Author keywords

Amiodarone; Implantable cardioverter defibrillator; Risk stratification; Sudden cardiac death

Indexed keywords

ADRENALIN; AMIODARONE; BRETYLIUM; ENCAINIDE; FLECAINIDE; LIDOCAINE; MORACIZINE; PROCAINAMIDE; QUINIDINE; SOTALOL;

ADVERSE DRUG REACTION; CLINICAL TRIAL; DEFIBRILLATOR; DRUG EFFICACY; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; SURVIVAL;

EID: 0033787777     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200010001-00009     Document Type: Review

References (43)

1. Cardiac arrest and sudden cardiac death
2. Sudden cardiac death-preventable-reversible
3. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment
4. Resuscitation from out-of hospital ventricular fibrillation: 4 Years follow-up
5. Outcome of out-of-hospital cardiac arrest in New York City
6. Precursors of sudden coronary death: Factors related to the incidence of sudden death
7. Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease
8. Management of ventricular arrhythmias
9. Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias
10. Cardiac pacing and pacemakers II
11. Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long-term outcome
12. Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testing
13. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation
14. Long-term survival of patients with malignant ventricular arrhythmias treated with antiarrhythmic drugs
15. The cardiac arrest in Seattle: Conventional versus amiodarone drug evaluation
16. Mortality in patients with implanted automatic defibrillators
17. Long-term outcome with the automatic implantable cardioverter defibrillator
18. Influence of implantable cardioverter defibrillators and long-term prognosis of survivors of out-of-hospital cardiac arrest
19. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal sustained ventricular arrhythmias
20. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias
21. A randomized study of the prevention of sudden death in patients with coronary artery disease
22. The relative contributions of early defibrillation and ACLS interventions to resuscitation and survival from prehospital cardiac arrest
23. Initial treatment of ventricular fibrillation: Defibrillation or drug therapy
24. Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia
25. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias
26. Use of intravenous amiodarone for emergency resuscitation of life-threatening ventricular arrhythmias
27. Randomized, double blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation
28. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation
29. Acute response and long-term follow up after intravenous amiodarone for hemodynamically destabilizing ventricular arrhythmias
30. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after a myocardial infarction
31. Ventricular premature complexes and sudden death after myocardial infarction
32. Mortality and morbidity in patients receiving encainide, flecainide or placebo: The Cardiac Arrhythmia Suppression Trial
33. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
34. Controlled trial of sotalol for one year after myocardial infarction
35. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction
36. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations
37. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
38. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death
39. The effect of clinical factors on the benefit of implantable defibrillators in the MUSTT trial
40. The Sudden Cardiac Death in Heart Failure Trial: Pilot study
41. Multicenter Automatic Defibrillator Implantation Trial II: Design and clinical protocol